Ignite Creation Date:
2025-12-25 @ 2:13 AM
Ignite Modification Date:
2025-12-27 @ 9:59 AM
Study NCT ID:
NCT00433160
Status:
COMPLETED
Last Update Posted:
2010-09-21
First Post:
2007-02-07
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 3 Clinical Trial of Teriparatide in Japan
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-01
Start Date Type:
None
Primary Completion Date:
2008-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-09
Completion Date Type:
ACTUAL
First Submit Date:
2007-02-07
First Submit QC Date:
None
Study First Post Date:
2007-02-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2009-08-17
Results First Submit QC Date:
None
Results First Post Date:
2009-09-30
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2010-09-14
Last Update Post Date:
2010-09-21
Last Update Post Date Type:
ESTIMATED